Select a Country


By investing in research and fostering a passionate environment devoted to innovation, we’re able to discover and create products that address patients’ most pressing health needs. Our portfolio of leading medicines, together with deep expertise across key areas of health and a robust pipeline of promising compounds, helps us make a difference for patients around the world.

Our Passion Helps Patients

Innovation is the cornerstone of AbbVie’s business as a global biopharmaceutical company. Our focus is on developing medicines that can offer strong clinical performance and, provide measurable patient benefit—particularly in areas where there is significant need—such as hepatitis C, neuroscience, immunology, oncology, chronic kidney disease and women’s health.

AbbVie’s approach to scientific innovation builds on an impressive track record of developing breakthrough science. Our scientists discovered and developed two of the first medications to treat HIV infection, helping to change the outlook for many patients impacted by this disease. Our work in immunology has benefited patients with rheumatoid arthritis, psoriasis, Crohn’s disease and other chronic, autoimmune conditions. We continue to advance scientific research across many disease areas.

Partnerships Play a Key Role

We also know that some of the most important medical breakthroughs often result from collaborative R&D agreements and from partnerships. To find potential new therapies for patients we look both inside and outside AbbVie for promising discoveries. We partner and collaborate with peer companies, universities, non-governmental organisations, as well as other relevant groups, to help find solutions for patients around the globe—because we recognise there are times when we can accomplish more together than alone.



Our core therapeutic areas include Hepatitis C (HCV), neuroscience, immunology, oncology, renal disease and women’s health.

Learn more »



We’re committed to advancing promising compounds and research to deliver essential therapies to patients.

View pipeline »



Our efforts are focused on areas where we believe we can have an even greater impact on the disease and how it is managed.

See our process »


You are now leaving the Web site. The AbbVie Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals and other products or uses of those products that are not approved in Canada.

Do you wish to continue?



You are about to leave an AbbVie Canada site, a Web site maintained by AbbVie Corporation. This link is provided for your convenience only. AbbVie Corporation takes no responsibility for the content of any Web site maintained by any third party and makes no representation as to the accuracy or completeness of any information contained on this or any subsequent link.

Do you wish to leave this site?